Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3results about How to "Definite inhibitory effect" patented technology

Application of forsythiaside A in preparing medicine for treating ACLY related diseases or medicine for inhibiting ACLY activity and medicine composition

The invention discloses an application of forsythiaside A in preparation of an ATP (adenosine triphosphate) citrate lyase (ACLY) inhibitor. In an enzyme activity test, the forsythiaside A has a very significant inhibition effect on ACLY, and the median inhibitory concentration (IC50) is 0.64 + / -0.09 [mu] M; on a cell model, the forsythiaside A can obviously reduce the triglyceride level; animal experiments show that forsythiaside A can reduce the weight, blood sugar, triglyceride, cholesterol level and the like of mice fed by high-fat, high-cholesterol and high-fructose feed. Therefore, the forsythoside A has a potential treatment value on ACLY related diseases, such as hyperlipidemia and atherosclerosis.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES

An indoline fused heterocyclic compound and a preparation method and application thereof

PendingCN122080006Adefinite inhibitory effectexpand areaOrganic active ingredientsOrganic chemistryQuinonePtru catalyst
This invention discloses an indoline fused heterocyclic compound, its preparation method, and its applications, belonging to the field of pharmaceutical synthesis technology. The method includes the following steps: using quinone imine monoketal and α,β-unsaturated cycloalkenyl ether as raw materials, and employing a Brønsted acid-phosphonic acid catalyst, a Brønsted acid-catalyzed [3+2] tandem cyclization reaction is carried out to obtain the indoline fused heterocyclic compound. The method provided by this invention features readily available raw materials and mild conditions, while also exhibiting high regioselectivity, chemoselectivity, and atom economy. The product can be efficiently separated by column chromatography, providing an excellent pathway for the large-scale preparation of this type of compound. Furthermore, the indoline fused heterocyclic compound provided by this invention has a significant inhibitory effect on the growth of human cervical cancer cells (HeLa), demonstrating good antitumor biological activity, which is of great positive significance for promoting the development of antitumor drugs.
Owner:QUJING NORMAL UNIV

Application of amentoflavone in preparing medicine for treating ACLY related diseases or medicine for inhibiting ACLY activity and medicine composition

PendingCN119112864Ahigh activitydefinite inhibitory effectOrganic active ingredientsAntipyreticDiseaseLyase
The invention discloses an application of amentoflavone in preparation of an ATP (adenosine triphosphate) citrate lyase (ACLY) inhibitor. In an enzyme activity test, amentoflavone has a very remarkable inhibition effect on ACLY, and the median inhibitory concentration (IC50) is 0.25 + / -0.06 mu M; animal experiments show that amentoflavone can reduce the body weight, blood sugar, liver weight, fat weight, triglyceride and the like of non-alcoholic fatty liver disease mice which are molded by high-fat, high-cholesterol and high-fructose feed diet. Therefore, the amentoflavone has a potential treatment value on ACLY related diseases, such as the non-alcoholic fatty liver disease.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES